Scientia Clinical Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Chronic kidney disease1 trial
• Chronic lymphocytic leukaemia1 trial
• Epilepsy1 trial

Phase

• Phase 13 trials

Status

• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Actio Biosciences, Inc.1 trial
• Klotho Sciences Australia Pty Ltd.1 trial
• Lomond Therapeutics Holdings, Inc.1 trial

Running trials

• Not yet recruiting

  A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers

  NCT07143331· Phase 1· Klotho Sciences Australia Pty Ltd.· Source

  Contact: Dr Youn Hoon Joo

• Recruiting

  A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

  NCT07156201· Phase 1· Actio Biosciences, Inc.· Source

  Contact: Christopher Argent, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Chronic kidney disease1 recruiting
• Epilepsy1 recruiting

Closed trials

• Completed

  Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

  NCT06787131· Phase 1· Lomond Therapeutics Holdings, Inc.· Source